Potential health gains for patients with metastatic renal cell carcinoma in daily clinical practice: A real-world cost-effectiveness analysis of sequential first- and second-line treatments

Saskia de Groot; Hedwig Blommestein; Ken Redekop; Stefan Sleijfer; L Kiemeney; E Oosterwijk; Carin Uyl - de Groot

doi:10.1371/journal.pone.0177364

Potential health gains for patients with metastatic renal cell carcinoma in daily clinical practice: A real-world cost-effectiveness analysis of sequential first- and second-line treatments

Saskia de Groot, Hedwig Blommestein, Ken Redekop, Stefan Sleijfer, L Kiemeney, E Oosterwijk, Carin Uyl - de Groot

Research output: Contribution to journal › Article › Academic › peer-review

10 Citations (Scopus)

10 Downloads (Pure)

Original language	Undefined/Unknown
Article number	e0177364
Journal	PLoS One (print)
Volume	12
Issue number	5
DOIs	https://doi.org/10.1371/journal.pone.0177364
Publication status	Published - 2017

Research programs

EMC NIHES-05-63-02 Quality
EUR ESHPM 02
EMC MM-03-86-01
EMC OR-01

Access to Document

10.1371/journal.pone.0177364

journal.pone.0177364.pdfFinal published version, 1.44 MB

http://hdl.handle.net/1765/100048

Cite this

de Groot, S., Blommestein, H., Redekop, K., Sleijfer, S., Kiemeney, L., Oosterwijk, E., & Uyl - de Groot, C. (2017). Potential health gains for patients with metastatic renal cell carcinoma in daily clinical practice: A real-world cost-effectiveness analysis of sequential first- and second-line treatments. PLoS One (print), 12(5), Article e0177364. https://doi.org/10.1371/journal.pone.0177364

@article{67bd2b1d449544e382cf6c96b5a2c6fa,

title = "Potential health gains for patients with metastatic renal cell carcinoma in daily clinical practice: A real-world cost-effectiveness analysis of sequential first- and second-line treatments",

author = "{de Groot}, Saskia and Hedwig Blommestein and Ken Redekop and Stefan Sleijfer and L Kiemeney and E Oosterwijk and {Uyl - de Groot}, Carin",

year = "2017",

doi = "10.1371/journal.pone.0177364",

language = "Undefined/Unknown",

volume = "12",

journal = "PLoS One (print)",

issn = "1932-6203",

publisher = "Public Library of Science",

number = "5",

}

de Groot, S , Blommestein, H , Redekop, K , Sleijfer, S, Kiemeney, L, Oosterwijk, E & Uyl - de Groot, C 2017, 'Potential health gains for patients with metastatic renal cell carcinoma in daily clinical practice: A real-world cost-effectiveness analysis of sequential first- and second-line treatments', PLoS One (print), vol. 12, no. 5, e0177364. https://doi.org/10.1371/journal.pone.0177364

Potential health gains for patients with metastatic renal cell carcinoma in daily clinical practice: A real-world cost-effectiveness analysis of sequential first- and second-line treatments. / de Groot, Saskia ; Blommestein, Hedwig ; Redekop, Ken et al.
In: PLoS One (print), Vol. 12, No. 5, e0177364, 2017.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Potential health gains for patients with metastatic renal cell carcinoma in daily clinical practice: A real-world cost-effectiveness analysis of sequential first- and second-line treatments

AU - de Groot, Saskia

AU - Blommestein, Hedwig

AU - Redekop, Ken

AU - Sleijfer, Stefan

AU - Kiemeney, L

AU - Oosterwijk, E

AU - Uyl - de Groot, Carin

PY - 2017

Y1 - 2017

U2 - 10.1371/journal.pone.0177364

DO - 10.1371/journal.pone.0177364

M3 - Article

C2 - 28531203

SN - 1932-6203

VL - 12

JO - PLoS One (print)

JF - PLoS One (print)

IS - 5

M1 - e0177364

ER -